Figure 4.

Forest plot of subgroup analyses of progression‐free survival based on computer algorithm, intent‐to‐treat population (Study MMY3004).

Abbreviations: CI, confidence interval; CrCl, creatine clearance rate; DVd, daratumumab + bortezomib + low‐dose dexamethasone; ECOG, Eastern Cooperative Oncology Group; EU, European Union; EVT/N, number of progression events or deaths/total number; IMiD, immunomodulatory drug; ISS, International Staging System; MM, multiple myeloma; NE, not estimated; Vd, bortezomib + low‐dose dexamethasone.